Metastatic ALK+ Non Small Cell Lung Cancer
1 clinical trials · Condition
◉ Watch Metastatic ALK+ Non Small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| Post Marketing Surveillance(PMS) Study of Lorviqua in Korea (NCT05599412) | Pfizer | 2023-05-22 |
Track Metastatic ALK+ Non Small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.